Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
CCSD Code

CCSD code S0608 – Sentinel lymph node biopsy for melanoma


Code Definition

S0608 is the CCSD code for sentinel lymph node biopsy for melanoma. It covers finding and removing the first lymph node, or nodes, that drain a primary melanoma. UK private medical insurers use it for this staging operation, which shows whether the cancer has reached the lymph nodes.

The descriptor names the node biopsy only. A same-day wide local excision, a completion node dissection and the histology all fall outside it. Each one is checked and claimed on its own.

Code system
CCSD schedule (UK private medical insurance)
Indication
Melanoma, staging of the regional lymph nodes
Schedule entry
S0608 Sentinel lymph node biopsy for melanoma
Billable
No
Code also known as
SLNB for melanoma, sentinel node biopsy, melanoma sentinel node staging
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CCSD code S0608 covers sentinel lymph node biopsy for melanoma, a staging operation on the first draining node or nodes.

NICE NG14 says to consider it above 1.0 mm Breslow thickness, or from 0.8 mm with ulceration, lymphovascular invasion or a raised mitotic index.

Pair S0608 with a C43 malignant melanoma code for the primary site, never an in situ D03 code.

The wide local excision, any completion node dissection and the histology sit outside the S0608 descriptor, so check each separately.

Insurer queries on S0608 usually come from a missing pre-authorization number, a thin operative note or a Breslow figure the reviewer can’t find.

What CCSD code S0608 covers, and where it stops

CCSD code S0608 is the UK private insurance code for sentinel lymph node biopsy for melanoma. It pays for finding and removing the first lymph node, or small cluster of nodes, that drains the primary tumor. NICE treats the operation as a staging step, and its melanoma guideline NG14 sets out who should be considered for it.

The result tells the team whether melanoma cells have reached the lymph nodes. That answer changes the stage, the follow-up plan and the case for adjuvant treatment.

The code is narrow, which is where billing teams slip. Its descriptor names the node biopsy alone. These usually sit outside it and need checking on their own:

  • The wide local excision of the primary scar, which is often done in the same operating session.
  • Completion or therapeutic lymph node dissection, a much larger operation on the whole nodal basin.
  • Lymphoscintigraphy, the nuclear medicine scan that maps the node before surgery.
  • Histopathology on the removed nodes, normally invoiced by the laboratory.

Before adding a second procedure code to the same claim, check the current CCSD schedule for unacceptable combinations. The CCSD codes guide explains how the schedule and its combination rules work.

Who qualifies for a sentinel node biopsy under NICE

Insurers judge medical necessity against national guidance, so the referral letter should mirror it. NICE NG14, updated in 2022, draws these lines:

SituationNICE NG14 position
Stage IA melanomaDo not offer SLNB or imaging (1.4.1)
Breslow 0.8 mm to 1.0 mmConsider SLNB if there is ulceration, lymphovascular invasion or a mitotic index of 2 or more (1.4.3)
Breslow over 1.0 mmConsider SLNB (1.4.4)
PregnancyDiscuss delaying SLNB until after the pregnancy (1.4.5)
Imaging before SLNBNot offered unless node or distant spread is suspected (1.4.2)

Notice the verb. NICE says “consider”, so the decision rests on a discussion with the patient and the skin cancer team. Record that conversation, because an insurer reviewer will look for it.

Inside the operation S0608 pays for

Here is the usual sequence for a melanoma sentinel node biopsy, from the scan to the report.

  1. Mapping. A small dose of radioactive tracer is injected around the excision scar, and lymphoscintigraphy shows which nodes take it up first.
  2. Marking. The surgeon marks the skin over the sentinel node. Many teams also inject blue dye at the start of surgery.
  3. Finding the node. A handheld gamma probe, and the blue staining where dye is used, guide the surgeon to the node through a small incision.
  4. Removal. The surgeon removes each node that is radioactive, blue or both, and records how many came out.
  5. Histology. The laboratory examines the nodes in detail. The report states whether melanoma deposits were found and how large they are.

Wide local excision often happens under the same anesthetic. That shared session is exactly why the claim needs two clearly separated procedure lines.

What the operative note has to prove

A reviewer reading an S0608 claim wants to see the staging logic in one place. A strong operative note or consultation letter records these points:

  • The primary melanoma site and the Breslow thickness from the original excision biopsy.
  • Any ulceration, lymphovascular invasion or mitotic rate that supports the indication.
  • The lymphoscintigraphy result, including which nodal basin lit up.
  • The number of sentinel nodes removed and the basin they came from.
  • Whether a wide local excision was done in the same session, recorded as its own procedure.
  • The discussion with the patient, and the skin cancer team’s agreement where relevant.

Pair S0608 with a C43 diagnosis code

UK insurers expect a WHO ICD-10 diagnosis on the claim. For S0608 that means a code from C43, malignant melanoma of skin, chosen by the primary site.

ICD-10 codePrimary melanoma site
C43.0Lip
C43.1Eyelid, including canthus
C43.2Ear and external auricular canal
C43.3Other and unspecified parts of face
C43.4Scalp and neck
C43.5Trunk
C43.6Upper limb, including shoulder
C43.7Lower limb, including hip
C43.8Overlapping malignant melanoma of skin
C43.9Malignant melanoma of skin, unspecified

Pick the most specific site the histology supports, and save C43.9 for cases where the site is undocumented. A D03 melanoma in situ code on an S0608 claim will draw a query, since in situ disease has no nodal staging role. The site list above comes from the WHO ICD-10 browser.

Follow one S0608 claim from referral to payment

An illustrative case shows where the paperwork lives. A patient’s excision biopsy reports a 1.4 mm melanoma on the left calf.

  1. The skin cancer team discusses SLNB with the patient, and the plastic surgeon books it with a wider excision.
  2. The practice calls the insurer with S0608, S0605 for the wider excision and C43.7, then receives a pre-authorization number.
  3. Lymphoscintigraphy maps a sentinel node in the left groin on the morning of surgery.
  4. The surgeon removes two sentinel nodes and performs the wider excision under one general anesthetic.
  5. The claim goes out with both procedure lines, the C43.7 code and the authorization number.
  6. The histology report follows, and the laboratory and the imaging provider invoice the insurer separately.

Step two carries the most risk. If the authorization only names S0608, the excision line can bounce even though the surgery was planned together.

Sorted by who sends each bill, the same episode shows how little of it sits on the S0608 line.

Table of one melanoma staging episode under CCSD code S0608
Only the node biopsy belongs on the S0608 line, so the excision, scan, histology and any later dissection each need their own route to payment. Scope taken from the S0608 descriptor as set out above.

Before you submit: The six-point check

Run this list before the claim leaves the billing team. Each line matches a reason insurers commonly query an S0608 claim.

  • The pre-authorization number covers this episode and every procedure code on the claim.
  • The C43 code matches the primary site in the histology report.
  • The Breslow thickness and any high-risk features appear in the letter or operative note.
  • The number of nodes removed and the nodal basin are written down.
  • Any excision on the same day sits on its own line, checked against the combination rules.
  • You looked the code up on the insurer’s current list, such as Bupa’s code finder, rather than an old spreadsheet.

Why S0608 claims stall, and how to fix each one

These are the common mistakes, each with the response that usually clears it.

  • Authorization for the biopsy only. The excision line gets rejected. Ask the insurer to extend the reference, then resubmit that line.
  • Indication not visible. The reviewer can’t find the Breslow figure. Attach the original histology report and the consultation letter.
  • Wrong diagnosis code. An in situ or unspecified code weakens the case. Recode to the specific C43 site and resubmit.
  • Dissection billed as biopsy. A completion node dissection was coded as S0608. Code the larger operation separately and authorize it first.
  • Late claim. Insurers set submission deadlines in their provider agreements. Check yours, then send with a short explanation.

Payer-specific acceptance rules differ, and the Bupa CCSD codes guide shows how one insurer applies them.

How Pabau keeps S0608 claims and authorizations on one record

A melanoma pathway produces a long paper trail. There is a referral, a histology report, a scan, an operation and a second report, often from different providers.

Pabau, the practice management and billing platform we build, keeps those pieces on the patient record. The pre-authorization number, its dates and sessions are tracked on the case. Pabau warns staff when an authorization is missing, before the claim goes out.

Pabau customizable consent and treatment forms
Pabau’s customizable forms capture consent and the clinical detail an S0608 claim relies on, such as the Breslow thickness, on the patient record.

UK claims, Bupa’s included, go out electronically through Healthcode using Pabau’s claims software for clinicians. The claim pulls the codes from the episode, so the biopsy and excision lines match what was authorized.

Pabau checkout screen with a completed Bupa invoice
Pabau links each invoice to the insurer, so an S0608 claim to Bupa sits next to the appointment and payment that produced it.

When a query lands weeks later, your team answers it from one screen. The authorization, the letters and the claim history are already together.

Keep every S0608 authorization on the record

Pabau tracks pre-authorization numbers on the case, flags missing ones and sends UK claims electronically through Healthcode, so melanoma staging claims go out complete.

Pabau practice management software dashboard

Conclusion

S0608 is a small operation with a staging decision riding on it. The claim clears review fastest when the file shows why the patient met the NICE threshold.

So put the Breslow figure, the node count and the authorization number where a reviewer can see them. Then keep the excision on its own line, authorized alongside the biopsy rather than after it.

Build those checks into the claim workflow rather than leaving them to memory. Book a demo to see how Pabau keeps authorizations, letters and CCSD claims on one patient record.

Continue your research

Continue your research

Need the wider CCSD picture? Bupa CCSD codes and procedure fee schedule explains how one major UK insurer applies the schedule.

Billing a neck node biopsy instead? CCSD code T8610 covers biopsy and sampling of cervical lymph nodes.

Coding the wider excision? CCSD code S0605 covers secondary excision of a malignant skin lesion on the trunk or limbs.

Treating skin cancer without surgery? CCSD code S0606 covers photodynamic therapy to malignant skin lesions.

Frequently asked questions

Is S0608 an OPCS-4 code?

No. S0608 belongs to the CCSD schedule, which UK private medical insurers use for claims. OPCS-4 is the classification the NHS uses to record procedures.

Can S0608 be used for a breast cancer sentinel node biopsy?

No. The S0608 descriptor names melanoma only. A sentinel node biopsy for another cancer, such as breast cancer, takes the code the CCSD schedule lists for that operation.

What are the side effects of a sentinel node biopsy?

Recovery is usually quick, since the incisions are small. Possible problems include wound infection, a fluid collection called a seroma, and lymphedema in the limb. Blue dye can tint the skin and urine for a while.

How long do sentinel node results take?

The laboratory report often takes a week or two, because the nodes are examined in thin slices with special stains. Results are normally discussed at a follow-up appointment.

Does a positive sentinel node mean more surgery?

Not automatically. NICE advises against routine completion node dissection for small deposits found on biopsy. The skin cancer team weighs scans, adjuvant treatment and surveillance instead.

Does private health insurance cover a melanoma sentinel node biopsy?

It depends on the member’s policy. Insurers generally expect the indication to follow NICE NG14 and the procedure to be pre-authorized. Confirm cover and get the authorization number before surgery.

Avatar photo
Monika Lazarevska
Content Writer

Monika Lazarevska writes content for owners and healthcare professionals who want clear, no-fluff content that actually helps them run their practice better. With a background in storytelling and SEO, she knows how to make even the driest topics worth reading. Off the clock, you'll find her in a café somewhere in Europe, probably with a good book and an even better coffee.
×